Metraipolis › archive › dc_cd633a00f9d2

Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel Disease — Europe PMC PMID:41598485

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41598485
DOI
10.3390/jcm15020547
License (as archived)
solo-consultazione
Archived
2026-11-06T22:28:19.118Z
SHA-256 of the archived text
0773ae29ff277d806e32cabfb958d47a5ca7d291dfa1de7e505cbecf34bc4781
Stable URL of this page
https://metraipolis.com/documento/dc_cd633a00f9d2

How to cite

Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel Disease — Europe PMC PMID:41598485 — Europe PMC (en), https://europepmc.org/article/MED/41598485 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd633a00f9d2 (Metraipolis archive dc_cd633a00f9d2, sha256 0773ae29ff277d806e32cabfb958d47a5ca7d291dfa1de7e505cbecf34bc4781)
BibTeX
@misc{dccd633a00f9d2,
  title = {Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel Disease — Europe PMC PMID:41598485},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41598485},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd633a00f9d2; sha256 0773ae29ff277d806e32cabfb958d47a5ca7d291dfa1de7e505cbecf34bc4781},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41598485. Agents can read the archived copy with the MCP tool read_document.